Hongwei Li

Title: Innovations of Hongwei Li in Obesity Treatment

Introduction

Hongwei Li is a notable inventor based in Nanjing, China. He has made significant contributions to the field of obesity treatment through his innovative research and development. His work focuses on creating effective methods for drug delivery targeting adipose tissue.

Latest Patents

Hongwei Li holds 1 patent for his invention titled "Adipose tissue-targeting polypeptide-verbascoside-nanogold particle derivative, preparation method and application thereof." This patent describes a method for preparing a derivative that targets adipose tissue, enhancing drug delivery and effectiveness in treating obesity. The method involves activating a carboxyl group of a cysteine residue, reacting verbascoside with sodium hydroxide, and esterifying the resulting compounds. The final product demonstrates good biocompatibility and significantly improves the targeted anti-obesity activity of the drug.

Career Highlights

Throughout his career, Hongwei Li has worked at reputable institutions, including the Affiliated Stomatological Hospital of Nanjing Medical University and Nanjing Medical University. His experience in these organizations has contributed to his expertise in medical research and innovation.

Collaborations

Hongwei Li has collaborated with notable colleagues such as Yi Yuan and Yaqin Zhang. Their combined efforts have further advanced research in the field of obesity treatment.

Conclusion

Hongwei Li's innovative work in developing targeted drug delivery systems represents a significant advancement in obesity treatment. His contributions are paving the way for more effective therapies in the medical field.